Literature DB >> 19505408

Efficacy and safety of anti-TNF-alpha therapy combined with cyclosporine A in patients with rheumatoid arthritis and concomitant hepatitis C virus infection.

C Giannitti, M Benucci, R Caporali, S Manganelli, F Bellisai, G D Sebastiani, M Galeazzi.   

Abstract

This study further expands our previous observation demonstrating the usefulness of combination therapy of anti-TNF-alpha and cyclosporine A in the treatment of rheumatoid arthritis and concurrent hepatitis C virus infection, as well its efficacy and safety in controlling HCV viremia and liver toxicity. Seven patients were included in the study; transaminase levels remained unchanged, HCV RNA serum levels decreased significantly and DAS 28 significantly improved after twelve month follow-up. No side effects were registered.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19505408     DOI： 10.1177/039463200902200233

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN： 0394-6320            Impact factor:   3.219


  8 in total

1.  Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study.

Authors:  Ko-Ming Lin; Tien-Tsai Cheng; Jing-Chi Lin; Chung-Jen Chen
Journal:  Clin Rheumatol       Date:  2015-05-05       Impact factor: 2.980

2.  Treatment of rheumatoid arthritis in patients with concomitant chronic hepatitis C infection.

Authors:  Amy M Joseph
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-02       Impact factor: 5.346

3.  Safety and efficacy of anti-tumor necrosis factors α in patients with psoriasis and chronic hepatitis C.

Authors:  Monica Salvi; Laura Macaluso; Cecilia Luci; Carlo Mattozzi; Giovanni Paolino; Yvonne Aprea; Stefano Calvieri; Antonio Giovanni Richetta
Journal:  World J Clin Cases       Date:  2016-02-16       Impact factor: 1.337

4.  Septic shock after seasonal influenza vaccination in an HIV-infected patient during treatment with etanercept for rheumatoid arthritis: a case report.

Authors:  Pasquale De Nardo; Rita Bellagamba; Angela Corpolongo; Elisa Gentilotti; Fabrizio Taglietti; Silvia Rosati; Mauro Galeazzi; Gian Domenico Sebastiani; Isabella Quinti; Emanuele Nicastri
Journal:  Clin Vaccine Immunol       Date:  2013-03-06

5.  Choice of Biologic Therapy for Patients with Rheumatoid Arthritis: The Infection Perspective.

Authors:  Filip De Keyser
Journal:  Curr Rheumatol Rev       Date:  2011-02

6.  Hepatitis C virus as a multifaceted disease: a simple and updated approach for extrahepatic manifestations of hepatitis C virus infection.

Authors:  Mahmoud Aboelneen Khattab; Mohammed Eslam; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2010-12-01       Impact factor: 0.660

Review 7.  Treatment of rheumatic diseases and hepatitis B virus coinfection.

Authors:  Anna Felis-Giemza; Marzena Olesińska; Katarzyna Świerkocka; Ewa Więsik-Szewczyk; Ewa Haładyj
Journal:  Rheumatol Int       Date:  2014-12-31       Impact factor: 2.631

8.  Prevalence of past and reactivated viral infections and efficacy of cyclosporine A as monotherapy or in combination in patients with psoriatic arthritis--synergy study: a longitudinal observational study.

Authors:  Delia Colombo; Sergio Chimenti; Paolo Grossi; Antonio Marchesoni; Sergio Di Nuzzo; Vito Griseta; Anna Gargiulo; Aurora Parodi; Lucia Simoni; Gilberto Bellia
Journal:  Biomed Res Int       Date:  2014-04-03       Impact factor: 3.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.